Targeting of plasmid DNA to renal interstitial fibroblasts by cationized gelatin

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 10, 2005, Pages 2007-2010

  Kushibiki, Toshihiro ^a   Nagata Nakajima, Natsuki ^b   Sugai, Manabu ^b   Shimizu, Akira ^b   Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Gelatin; Gene targeting; Renal interstitial fibrosis

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GELATIN; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; FIBROBLAST; KIDNEY CORTEX; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; URETER; URETER OBSTRUCTION;

ANIMALS; CATIONS; DNA; FIBROBLASTS; GELATIN; GREEN FLUORESCENT PROTEINS; KIDNEY; MICE; PLASMIDS;

EID: 26444470808     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.28.2007     Document Type: Article

References (31)

1. Stahl P. J., Felsen D., Am. J. Pathol., 159, 1187-1192 (2001).
2. Muller G. A., Zeisberg M., Strutz F., Nephrol. Dial. Transplant., 15, 76-77 (2000).
3. Remuzzi G., Bertani T. N., Engl. J. Med., 339, 1448-1456 (1998).
4. Eikmans M., Baelde J. J., de Heer E., Bruijn J. A., J. Pathol., 200, 526-536 (2003).
5. Zeisberg M., Strutz F., Muller G. A., Curr. Opin. Nephrol. Hypertens., 10, 315-320 (2001).
6. Fine L. G., Ong A. C., Norman J. T., Eur. J. Clin. Invest., 23, 259-265 (1993).
7. Kuncio G. S., Neilson E. G., Haverty T., Kidney Int., 39, 550-556 (1991).
8. Yamamoto T., Noble N. A., Cohen A. H., Nast C. C., Hishida A., Gold L. I., Border W. A., Kidney Int., 49, 461-469 (1996).
9. Rocco M. V., Chen Y., Goldfarb S., Ziyadeh F. N., Kidney Int., 41, 107-114. (1992).
10. Wolf G., Sharma K., Chen Y., Ericksen M., Ziyadeh F. N., Kidney Int., 42, 647-656 (1992).
11. Razzaque M. S., Kumatori A., Harada T., Taguchi T., Nephron, 80, 434-443 (1998).
12. Border W. A., Okuda S., Languino L. R., Sporn M. B., Ruoslahti E., Nature (London), 346, 371-374 (1990).
13. Akagi Y., Isaka Y., Arai M., Kaneko T., Takenaka M., Moriyama T., Kaneda Y., Ando A., Orita Y., Kamada T., Ueda N., Imai E., Kidney Int., 50, 148-155 (1996).
14. Border W. A., Noble N. A., Yamamoto T., Harper J. R., Yamaguchi Y., Pierschbacher M. D., Ruoslahti E., Nature (London), 360, 361-364 (1992).
15. Isaka Y., Brees D. K., Ikegaya K., Kaneda Y., Imai E., Nat. Med., 2, 418-423 (1996).
16. Tabata Y., Ikada Y., Adv. Drug Deliv. Rev., 31, 287-301 (1998).
17. Kushibiki T., Tomoshige R., Fukunaka Y., Kakemi M., Tabata Y., J. Control. Release, 90, 207-216 (2003).
18. Fukunaka Y., Iwanaga K., Morimoto K., Kakemi M., Tabata Y., J. Control. Release, 80, 333-343 (2001).
19. Kushibiki T., Tabata Y., Curr. Drug Deliv., 1, 153-163 (2004).
20. Kushibiki T., Matsumoto K., Nakamura T., Tabata Y., Gene Ther., 11, 1205-1214 (2004).
21. Snyder S. L., Sobocinski P. Z., Anal. Biochem., 64, 284-288 (1975).
22. Klahr S., Morrissey J., Am. J. Physiol. Renal Physiol., 283, F861-875 (2002).
23. Diamond J. R., Ricardo S. D., Klahr S., Semin. Nephrol., 18, 594-602 (1998).
24. Maxwell P. H., Ferguson D. J., Nicholls L. G., Johnson M. H., Ratcliffe P. J., Kidney Int., 52, 715-724 (1997).
25. Sharma A. K., Mauer S. M., Kim Y., Michael A. F., Kidney Int., 44, 774-788 (1993).
26. Zhu G., Nicolson A. G., Cowley B. D., Rosen S., Sukhatme V. P., Gene Ther., 3, 298-304 (1996).
27. Tsujie M., Isaka Y., Ando Y., Akagi Y., Kaneda Y., Ueda N., Imai E., Hori M., Kidney Int., 58, 1973-1980 (2000).
28. Hosseinkhani H., Aoyama T., Yamamoto S., Ogawa O., Tabata Y., Pharm. Res., 19, 1471-1479 (2002).
29. Maeda H., Fang J., Inutsuka T., Kitamoto Y., Int. Immunopharmacol., 3, 319-328 (2003).
30. Zauner W., Kichler A., Schmidt W., Sinski A., Wagner E., Biotecniques, 20, 905-913 (1996).
31. Midoux P., Monsigny M., Bioconjugate Chem., 10, 406-411 (1999).